News|Articles|August 5, 2014

BioSpectra Opens Contract Manufacturing Facility

Author(s)Pharmaceutical Technology Editors

BioSpectra's Pennsylvania facility will manufacture biological buffers, pharmaceutical excipients, and laboratory reagents.

BioSpectra opened an FDA-registered facility in Bangor, Pennsylvania, US for contract-manufactured products for pharmaceutical, biopharmaceutical, and drug manufacturing markets.

BioSpectra provides custom cGMP purifications, acidifications, acid/base reactions, custom formulations, and particle manipulation backed by fully-documented regulatory support using ICHQ7 manufacturing systems. The company produces biological buffers, pharmaceutical excipients, and laboratory reagents.

Source: BioSpectra

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.